Odyssey Therapeutics Inc: H.C. Wainwright assumes coverage with buy rating; target price $40
ODTX•H.C. Wainwright assumed coverage of Odyssey Therapeutics Inc with a buy rating and a $40 target price.
Related News
Amplitude, Inc.: Citigroup raises target price to $18 from $11
AMPL•
Venu Holding to host fiscal 2026 third-quarter earnings call
VENU•
Enbridge names Michele Harradence to succeed Greg Ebel as CEO when he retires in January 2027
ENB•
BMO raises Teleflex target price to $169 from $159
TFX•
Stifel cuts Alpha and Omega Semiconductor target price to $27 from $34
AOSL•